GUIDELINES FOR SUBMITTING ABSTRACTS
The 14th Annual International Meeting of the Academy of Breastfeeding Medicine
November 6-8, 2009
Williamsburg, Virginia, USA
SUBMISSION DEADLINE: Abstracts must be received by JUNE 9, 2008.
Abstracts should be submitted via e-mail to abstracts@bfmed.org.
If you are not able to email the abstract you may fax or mail it, but you must also
mail an electronic version (CD-R, CD-RW).
1) Subject: Abstracts may be related to any category listed on the Abstract Form or to other issues relevant to breastfeeding
medicine.
2) Authors: Abstracts may be submitted by physicians, medical students and those holding post graduate degrees or
students working to attain such degrees. Abstracts submitted by non-physicians must be sponsored by a member in good
standing of the Academy of Breastfeeding Medicine. The sponsor must attest to the authenticity of the research (see
sponsor attestation document). The first author/presenting author and sponsor (in case of non-physician first authorship)
must sign the abstract submission; an electronic signature is acceptable.
3) Font: Please use Times New Roman font, 12 pt or 12 pitch. All accepted abstracts will be reproduced as submitted
and therefore should be proofread carefully.
4) Abstract Formatting
a) TITLE in CAPITAL LETTERS and BOLD FONT.
b) Authors listed in order and including first and last name followed by postgraduate degrees only (MD, DO, PhD,
MBBS, etc…). Do NOT include non-postgraduate degrees such as RN, BSN, IBCLC, FACOG, FAAP, etc…). You
may include FABM.
c) Place an asterisk after the presenting author’s name.
d) Include the presenting author’s department, institution, credentials (academic degrees only), and contact information.
5) Body of Abstract
a) The body of the abstract MUST be limited to no more than 250 words (Body of the abstract includes
background, objective, methods, results and conclusions – and does NOT include Funding sources).
b) Abstract MUST be structured as follows:
i) Background
ii) Objective: Why was the research conducted (purpose, aims, etc.)?
iii) Methods: How was the research conducted (randomized trial, observational study, survey etc)? What types of
analyses were conducted on the data?
iv) Results: Summarize findings in sufficient detail to support conclusions. DO NOT STATE THAT RESULTS
WILL BE PRESENTED.
v) Conclusions: Statement of conclusions. DO NOT STATE THAT CONCLUSIONS WILL BE DESCRIBED.
vi) Funding sources: list all granting agencies and/or funding support after the body of the abstract
6) Abstracts will be reviewed by an Abstract Review Committee. The first author and sponsor, if applicable, will
be notified by mid July regarding acceptance. Presentations may be accepted for either platform or poster
presentation. All abstract presenters MUST register and attend the 14th Annual International Meeting of the Academy of
Breastfeeding Medicine.
7) First authors of accepted abstracts who are non-physicians MUST register and attend the physician’s meeting of the
Academy of Breastfeeding Meeting. Please contact the ABM office for information about meeting registration and fees
as soon as possible after notification of acceptance is received.
8) Accepted abstracts will be published in the peer-reviewed journal, Breastfeeding Medicine, Volume 4, Issue 3.
9) If you mail an abstract – please mail it to: 2009 Meeting - Academy of Breastfeeding Medicine
140 Huguenot St., 3rd floor
New Rochelle, NY 10801, USA
Fax: 914.740.2101 (Attn: ABM)
Email: abstracts@bfmed.org; Website: www.bfmed.org
ABSTRACT SUBMISSION FORM
The 14 Annual International Meeting of the Academy of Breastfeeding Medicine
th
November 6-8, 2009
Williamsburg, Virginia USA
SUBMISSION DEADLINE: Abstracts must be received by JUNE 9, 2009.
Please submit abstracts via e-mail to abstracts@bfmed.org. If you are not able to email your abstract
you may send by fax or mail, but you must also mail an electronic version (CD-R etc).
Presenting Author’s Name Anne Eglash
Postgraduate Degree(s) MD, FABM, IBCLC
Institution/Department University of Wisconsin School of Medicine and Public Health
Professional Title Clinical Associate Professor
E-mail areglash@wisc.edu
th
Address 600 N. 8 St.
City Mt. Horeb State/Province WI Zip Code/Postal Code 53705
Country USA Telephone 608-437-3064 Fax 608-437-4542
Signature __________________________________________________________________________________________________
Signature of ABM member sponsoring submission (if applicable)____________________________________________________
Indicate category of abstract:
Clinical outcomes of infants
Economic impact of breastfeeding
Women’s health
Medical education
Program development and financing
X
Human milk composition
Lactation management strategies
Clinical practice
International programs
Other
WORD LIMIT 250 words. Abstracts longer than 250 words will NOT be reviewed
TITLE: Bacterial Culture Outcomes from Spiked Breastmilk; the Effects of Supplemental Chemicals
Authors: Carol Hulland MEd, Anne Eglash* MD, FABM, Jose Pantoja MV, MS, Carol Spiegel PhD,
Pam Ruegg DVM, MPVM, Richard Proctor, MD
Institutions: University of Wisconsin School of Medicine and Public Health, and University of
Wisconsin Department of Dairy Science
Background
Lactating women who have chronic breast and nipple pain are at risk for weaning. There is evidence that a
subset of CBNP is due to chronic infections in the breast. Antibacterial properties in breastmilk make it
difficult to interpret breastmilk culture results.
Objective
This study describes the effect of adding chemicals to breastmilk on bacterial culture results.
Method
Breastmilk samples were supplemented as follows: (a) milk only (b) ferrous ammonium sulfate with
ascorbic acid, (c) 2mg/mL sodium citrate.
Five bacteria were used to spike the milk samples. Two isolates were coagulase negative
staphylococci , two were Staphylococcus aureus, and one was a small colony variant Staphylococcus aureus.
The milk samples were cultured as follows; immediately after spiking milk; 8 hours after initial plating, and
20 hours after first plating. Numbers of cfus were counted after 48 hours, and again after 5 days.
Result
Total bacteria and staph species growth declined as more time elapsed after initial spiking but before
culturing.
Two supplements supported greater bacterial growth, for both total counts, and for staphylococcus species
only. These were unsupplemented milk, and milk supplemented with 2mg/mL sodium citrate.
Total staphylococcus counts from all supplements including plain milk declined over 20 hours before
culturing.
Conclusion
Supplementing breastmilk samples with 2mg/ml sodium citrate may enhance bacterial culture growth
including growth of staphylococcus. Adding the supplement to the breastmilk sample and culturing the
sample immediately may also yield greater bacterial growth.
Funding
The Department of Family Medicine, University of Wisconsin School of Medicine and Public Health
Return Abstract to: 2009 Meeting - Academy of Breastfeeding Medicine
140 Huguenot St., 3r floor; New Rochelle, NY 10801, USA
Fax: 914.740.2101 (Attn: ABM)
Email: abstracts@bfmed.org; Website: www.bfmed.org
SPONSORSHIP ATTESTATION
As an Academy of Breastfeeding Medicine member in good standing I am sponsoring the submission of
this research abstract for________________________ (first author). In signing this document I verify
that I am familiar with the author and can attest to the authenticity of the research. Furthermore, I
confirm that the order of authorship reflects each author’s intellectual contribution to the research
presented.
Signed: ________________________________________ Date:_______________________________